MD Saiful Islam Khan
Pfizer (Nyse:Pfe) On Saturday, he announced that his colorectal braft cancer therapy, as part of the combined regime, reduced the size of the tumor (confirmed by the Objective Response rate) in a late -phase test with a clinically significant and statistically significant effect.
Following data reading from
